首页> 外文OA文献 >Chronic treatment with atypical neuroleptics induces striosomal FosB/ΔFosB expression in rats
【2h】

Chronic treatment with atypical neuroleptics induces striosomal FosB/ΔFosB expression in rats

机译:非典型抗精神病药的慢性治疗诱导大鼠纹状体FosB /ΔFosB表达

摘要

Background Studies have shown that neuroleptics regulate expression of the transcription factor FosB/ΔFosB in the striatum, including the accumbens and caudate-putamen; however, the striatum is also divided into another structural dimension, the striosome and matrix compartments. The precise distribution of FosB/ΔFosB induced by chronic neuroleptics in these striatal compartments is poorly understood. Methods Rats received either single acute injections or chronic injections of clozapine (0 or 20 mg/kg, intraperitoneally [IP]), olanzapine (0 or 5 mg/kg, IP), or haloperidol (0 or 1. 5 mg/kg, IP) for 25 days. The levels and compartmental distribution of FosB/ΔFosB were examined. Results Chronic clozapine induced clustered FosB/ΔFosB expression within striosomes of the caudate-putamen. This pattern was due to increased levels of FosB/ΔFosB in striosomes within the ventrolateral caudate-putamen and reduced levels of basal FosB/ΔFosB in the matrix in the entire caudate-putamen. In contrast, chronic haloperidol increased FosB/ΔFosB equally within the matrix and striosomes throughout the entire caudate-putamen. Chronic olanzapine induced an intermediate pattern. Conclusions The relative absence of FosB/ΔFosB expression in the matrix correlates with the lack of parkinsonism of atypical neuroleptics. Expression of FosB/ΔFosB in the matrix may contribute to parkinsonism of typical neuroleptics.
机译:背景研究表明,精神抑制药可调节纹状体中的转录因子FosB /ΔFosB的表达,包括伏伏伏隔和尾状丘脑。然而,纹状体也分为另一个结构维度,即脂质体和基质区室。慢性精神抑制药在这些纹状体区室中诱导的FosB /ΔFosB的精确分布了解甚少。方法大鼠接受氯氮平(0或20 mg / kg,腹膜内[IP]),奥氮平(0或5 mg / kg,IP)或氟哌啶醇(0或1. 5 mg / kg, IP)25天。检查了FosB /ΔFosB的水平和区室分布。结果慢性氯氮平诱导的尾状-壳状虫核糖体中簇状的FosB /ΔFosB表达。这种模式是由于在整个尾状-丘状核的腹侧尾状-丘状核内的基质中FosB /ΔFosB的浓度升高和基质中的基础FosB /ΔFosB的浓度降低。相反,慢性氟哌啶醇在整个尾状-丘脑中均在基质和核小体中平均增加FosB /ΔFosB。慢性奥氮平诱发了一种中间模式。结论基质中FosB /ΔFosB表达的相对缺失与非典型抗精神病药的帕金森氏症缺乏相关。 FosB /ΔFosB在基质中的表达可能有助于典型抗精神病药的帕金森氏症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号